All News

Watch Dr. Dickran Kazandjian, from the Sylvester Comprehensive Cancer Center at the University of Miami, discuss available immunotherapy options during the CURE® Educated Patient® Multiple Myeloma Summit.

A recently launched clinical trial of NTX1088 will determine if the novel drug can help overcome immune checkpoint inhibition resistance in patients with locally advanced or metastatic solid tumors.

The combination of pelareorep, Tecentriq, gemcitabine and Abraxane was granted FDA fast-track designation after demonstrating a 69% objective response rate in patients with advanced/metastatic pancreatic ductal adenocarcinoma.

Dry shampoo has been my go-to when I was unable to shower, but a recent recall alert regarding a cancer-causing ingredient made me rethink the convenience associated with the product.

From Toby Keith providing fans with an update since his stomach cancer diagnosis to Katie Couric donating $25,000 worth of baby formula to moms with breast cancer, here’s what’s happening in the cancer space this week.

Watch Dr. C. Ola Landgren and Dr. David Coffey answer questions about novel treatments and the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

This article is sponsored by AstraZeneca and Merck.

Rezlidhia was approved for patients with acute myeloid leukemia based on study results showing that more than one-third of patients experienced a complete remission after taking the drug.

Cancer can negatively affect fertility after treatment, and women should talk with their doctor about their personal risk and preservation options.

Educating people about cancer can not only be life-saving, but is also a kind thing to do. I was reminded of this by a post from a children’s author who died of cancer.

A nurse shares what it was like when her daughter was diagnosed with an aggressive cancer during the beginning of the COVID-19 pandemic.

Watch Dr. David Coffey, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

After being diagnosed with cancer, an amazing posse of loved ones formed around me, but perhaps nobody was as helpful as my loving husband.

A recently conducted study found that for some patients, chemotherapy-induced hiccups were worse than nausea and vomiting.

After experiencing another cancer scare (which thankfully turned out to be OK), I purchased a wig and a fun outfit to wear, prompting my family to think my cancer had returned.

For National Family Caregivers Month, lymphoma caregiver Rickey Briskman explains the importance of caregivers putting themselves first.

Watch Dr. C. Ola Landgren, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss novel treatments for newly diagnosed patients during the CURE® Educated Patient® Multiple Myeloma Summit.

Patient-reported quality of life was better for patients with resected melanoma who received Keytruda compared to interferon or Yervoy, study results showed.

An expert offers three steps that patients can take to become more comfortable and confident with their ostomy after undergoing surgery for gastric cancer.

Cancer made me realize that there is more to life than just work.

In a recent interview with Cancer Horizons®, the medical liaison for KidneyCAN, discussed the basics of kidney cancer and what she thinks patients should know.

Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.

For some, sticking to healthy habits can be difficult, but when I was going through cancer, I felt that my life depended on it.

CURE® surveyed its audience to see how they cope with “scanxiety,” the anxiety surrounding cancer scans. Here’s what they had to say.

It isn’t enough to say that cancer clinical trials need more diversity and patient support; we must take action.

A new study may provide hope that future treatments can delay androgen-deprivation therapy and prolong survival in patients with oligometastatic prostate cancer.

Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Communication is key with cancer survivorship, especially for rare diseases like male breast cancer.